Design, Synthesis, and Biological Evaluation of PKD Inhibitors.
about
Protein kinase D enzymes: novel kinase targets in pancreatic cancerA targeted library screen reveals a new inhibitor scaffold for protein kinase DProtein Kinase Inhibitors CK59 and CID755673 Alter Primary Human NK Cell Effector FunctionsSustained protein kinase D activation mediates respiratory syncytial virus-induced airway barrier disruption.In vitro cytotoxicity, pharmacokinetics, tissue distribution, and metabolism of small-molecule protein kinase D inhibitors, kb-NB142-70 and kb-NB165-09, in mice bearing human cancer xenografts.A bifunctional dimethylsulfoxide substitute enhances the aqueous solubility of small organic molecules.New pyrazolopyrimidine inhibitors of protein kinase d as potent anticancer agents for prostate cancer cellsPromiscuous actions of small molecule inhibitors of the protein kinase D-class IIa HDAC axis in striated muscleFunctional and therapeutic significance of protein kinase D enzymes in invasive breast cancer.Regulation of membrane KCNQ1/KCNE1 channel density by sphingomyelin synthase 1.Protein kinase D isoforms: new targets for therapy in invasive breast cancers?Protein kinase D signaling in cancer: A friend or foe?An uncharged oxetanyl sulfoxide as a covalent modifier for improving aqueous solubility.Protein kinase D2: a versatile player in cancer biology.Enantioselective Phosphine-Catalyzed Formal [4+4] Annulation of α,β-Unsaturated Imines and Allene Ketones: Construction of Eight-Membered Rings.Diversity-oriented synthesis of fused thioglycosyl benzo[e][1,4]oxathiepin-5-ones and benzo[f][1,4]thiazepin-5(2H)-ones by a sequence of palladium-catalyzed glycosyl thiol arylation and deprotection-lactonization reactions.Hippocampal protein kinase D1 is necessary for DHPG-induced learning and memory impairments in rats.
P2860
Q26801854-856857EB-EEDD-40CA-951E-EC7FB80B3756Q28483837-9417FA26-22DE-4D8B-917F-143496DA4731Q28703128-5030B8D7-0F87-43E4-967F-F8C4B4D7E62BQ30414082-FB2D703D-D834-4780-9DA7-5F2AE49D8AEDQ30414963-B8B791F9-51CA-4C07-B0CA-2E64020625A6Q34108978-51D9DB29-48ED-4417-AF5E-757FCFEA0003Q35005813-2BB4F72E-C471-4F74-B406-1AAC7D00BDC4Q35541203-7151D2D0-A83B-4B2B-BA2E-8526F8AEA4BCQ36200052-7BA30CEA-2B84-4327-9AD4-3FDC2F0B9164Q37139398-76B4D9DA-45DA-4106-91D0-7B7A0F974D30Q37377802-AA0EF26D-727D-4CA3-B511-C25C421B5184Q39348454-C60CF2F9-6A88-4A2F-BB27-A890E0D78C89Q42808123-9DB17E4B-E2F9-4A81-BFD2-BE54CC0BF52BQ47273020-29826FCB-36AA-4250-B10A-E23080125B05Q47785632-27D7F0EA-81C5-48AF-B01E-00CA5E2E6181Q50935791-D39FD2D2-A100-40F4-9DE4-8F6FF602D08EQ54118045-C7494261-BF86-4F4F-8E7A-3344F285F830
P2860
Design, Synthesis, and Biological Evaluation of PKD Inhibitors.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Design, Synthesis, and Biological Evaluation of PKD Inhibitors.
@ast
Design, Synthesis, and Biological Evaluation of PKD Inhibitors.
@en
type
label
Design, Synthesis, and Biological Evaluation of PKD Inhibitors.
@ast
Design, Synthesis, and Biological Evaluation of PKD Inhibitors.
@en
prefLabel
Design, Synthesis, and Biological Evaluation of PKD Inhibitors.
@ast
Design, Synthesis, and Biological Evaluation of PKD Inhibitors.
@en
P2093
P2860
P50
P1433
P1476
Design, Synthesis, and Biological Evaluation of PKD Inhibitors.
@en
P2093
Courtney R Lavalle
Kara M George
Karla Bravo-Altamirano
Manuj Tandon
Marie-Céline Frantz
Q Jane Wang
P2860
P304
P356
10.3390/PHARMACEUTICS3020186
P577
2011-01-01T00:00:00Z